Potent inhibition of human cytochrome P450 1 enzymes by dimethoxyphenylvinyl thiophene

Archives of Pharmacal Research

Volumn 27, Issue 2, 2004, Pages 199-205

  Lee, Sang Kwang ^a   Kim, Yongmo ^a   Mie, Young Kim ^a   Kim, Sanghee ^b   Chun, Young Jin ^a  

^a Chung Ang University   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Cytochrome P450 1 enzyme; Dimethoxyphenylvinyl thiophene; Enzyme inhibitor

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOCHROME P450; CYTOCHROME P450 1A1; DIMETHOXYPHENYLVINYL THIOPHENE; ENZYME INHIBITOR; ISOENZYME; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; RECOMBINANT PROTEIN; THIOPHENE DERIVATIVE;

ANIMAL; ARTICLE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; ESCHERICHIA COLI; HUMAN; IN VITRO STUDY; KINETICS; LUNG; METABOLISM; MICROSOME; RAT; SYNTHESIS;

ANIMALS; ANTINEOPLASTIC AGENTS; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 ENZYME SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; ESCHERICHIA COLI; HUMANS; ISOENZYMES; KINETICS; LUNG; MICROSOMES; NADP; RATS; RECOMBINANT PROTEINS; THIOPHENES;

EID: 4644226790     PISSN: 02536269     EISSN: 02536269     Source Type: Journal    
DOI: 10.1007/BF02980107     Document Type: Article

References (33)

1. Burke, M. D., Thompson, S., Elcombe, C. R., Halpert, J., Haaparanta, T., and Mayer, R. T., Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450. Biochem. Pharmacol., 34, 3337-3345 (1985).
2. Cai, Y., Baer-Dubowska, W., Ashwood-Smith, M. J., Ceska, O., Tachibana, S., and DiGiovanni, J., Mechanism-based inactivation of hepatic ethoxyresorufin O-dealkylation activity by naturally occurring coumarins. Chem. Res. Toxicol., 9, 729-736 (1996).
3. Chang, T. K., Lee, W. B., and Ko, H. H., Trans-resveratrol modulates the catalytic activity and mRNA expression of the procarcinogen-activating human cytochrome P450 1B1. Can. J. Physiol. Pharmacol., 78, 874-881 (2000).
4. Cheong, H., Ryu, S. Y., and Kim, K. M., Anti-allergic action of resveratrol and related hydroxystilbenes. Planta Med., 65, 266-268 (1999).
5. Chun, Y. J., Kim, M. Y., and Guengerich, F. P., Resveratrol is a selective human cytochrome P450 1A1 inhibitor. Biochem. Biophys. Res. Commun., 262, 20-24 (1999).
6. Chun, Y. J., Kim, S., Kim, D., Lee, S. K., and Guengerich, F. P., A new selective and potent inhibitor of human cytochrome P450 1B1 and its application to antimutagenesis. Cancer Res., 61, 8164-8170 (2001a).
7. Chun, Y. J., Ryu, S. Y., Jeong, T. C., and Kim, M. Y., Mechanismbased inhibition of human cytochrome P450 1A1 by rhapontigenin. Drug Metab. Dispos., 29, 389-393 (2001b).
8. Ciolino, H. P., Wang, T. T., and Yeh, G. C., Diosmin and diosmetin are agonists of the aryl hydrocarbon receptor that differentially affect cytochrome P450 1A1 activity. Cancer Res., 58, 2754-2760 (1998).
9. Ciolino, H. P. and Yeh, G. C., The flavonoid galangin is an inhibitor of CYP1A1 activity and an agonist/antagonist of the aryl hydrocarbon receptor. Br. J. Cancer, 79, 1340-1346 (1999).
10. Dawling, S., Roodi, N., and Parl, F. F., Methoxyestrogens exert feedback inhibition on cytochrome P450 1A1 and 1B1. Cancer Res., 63, 3127-3132 (2003).
11. Doostdar, H., Burke, M. D., and Mayer, R. T., Bioflavonoids: selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1. Toxicology, 144, 31-38 (2000).
12. Fremont, L., Biological effects of resveratrol. Life Sci., 66, 663-673 (2000).
13. Guengerich, F. P., Analysis and characterization of enzymes, In Hayes, A.W. (Ed). Principles and Methods of Toxicology. Raven Press, New York, pp. 1259-1313, (1994).
14. Guengerich, F. P., Martin, M. V., Guo, Z., and Chun, Y. J., Purification of functional recombinant P450s from bacteria. Methods Enzymol., 272, 35-44 (1996).
15. Guengerich, F. P. and Shimada, T., Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem. Res. Toxicol., 4, 391-407 (1991).
16. Inouye, K., Saito, A., Orita, M., Tonomura, B., Imaishi, H., and Ohkawa, H., Inhibitory effects of 1,4-naphthoquinone derivatives on rat cytochrome P4501A1-dependent monooxygenase activity in recombinant yeast microsomes. J. Biochem., 127, 1041-1046 (2000).
17. Jean, P., Lopez-Garcia, P., Dansette, P., Mansuy, D., and Goldstein, J. L., Oxidation of tienilic acid by human yeastexpressed cytochromes P-450 2C8, 2C9, 2C18 and 2C19. Evidence that this drug is a mechanism-based inhibitor specific for cytochrome P-450 2C9. Eur. J. Biochem., 241, 797-804 (1996).
18. Kim, S., Ko, H., Park, J. E., Jung, S., Lee, S. K., and Chun, Y. J., Design, synthesis, and discovery of novel trans-stilbene analogues as potent and selective human cytochrome P450 1B1 inhibitors. J. Med. Chem., 45, 160-164 (2002a).
19. Kim, Y. M., Yun, J., Lee, C. K., Lee, H., Min, K. R., and Kim, Y., Oxyresveratrol and hydroxystilbene compounds. Inhibitory effect on tyrosinase and mechanism of action. J. Biol. Chem., 277, 16340-16344 (2002b).
20. Kleiner, H. E., Vulimiri, S. V., Reed, M. J., Uberecken, A., and DiGiovanni, J., Role of cytochrome P450 1a1 and 1b1 in the metabolic activation of 7,12-dimethylbenz[ a]anthracene and the effects of naturally occurring furanocoumarins on skin tumor initiation. Chem. Res. Toxicol., 15, 226-235 (2002).
21. Koenigs, L. L., Peter, R. M., Hunter, A. P., Haining, R. L., Rettie, A. E., Friedberg, T., Pritchard, M. P., Shou, M., Rushmore, T. H., and Trager, W. F., Electrospray ionization mass spectrometric analysis of intact cytochrome P450: identification of tienilic acid adducts to P450 2C9. Biochemistry, 38, 2312-2319 (1999).
22. Mays, D., Hilliard, J., Wong, D., Chambers, M., Park, S., Gelboin, H., and Gerber, N., Bioactivation of 8-methoxypsoralen and irreversible inactivation of cytochrome P-450 in mouse liver microsomes: modification by monoclonal antibodies, inhibition of drug metabolism and distribution of covalent adducts . J. Pharmacol. Exp. Ther., 254, 720-731 (1990).
23. Nimmanpisut, S., Chudapongse, P., and Ratanabanangkoon, K., Effects of 2,4,3′,5′-tetrahydroxystilbene on oxidative phosphorylation by rat liver mitochondria. Biochem. Pharmacol., 25, 1245-1248 (1976).
24. Obach, R. S., Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression. J. Pharmacol. Exp. Ther., 294, 88-95 (2000).
25. O'Donnell, J. P., Dalvie, D. K., Kalgutkar, A. S., and Obach, R. S., Mechanism-based inactivation of human recombinant P450 2C9 by the nonsteroidal anti-inflammatory drug suprofen. Drug Metab. Dispos., 31, 1369-1377 (2003).
26. Omura, T. and Sato, R., The carbon-monoxide binding pigment of liver microsomes. J. Biol. Chem., 239, 2370-2378 (1964).
27. Parikh, A., Gillam, E. M., and Guengerich, F. P., Drug metabolism by Escherichia coli expressing human cytochromes P450. Nat. Biotechnol., 15, 784-788 (1997).
28. Pervaiz, S., Resveratrol: from grapevines to mammalian biology. FASEB J., 17, 1975-1985 (2003).
29. Schwarz, D., Kisselev, P., and Roots, I., St. John's wort extracts and some of their constituents potently inhibit ultimate carcinogen formation from benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1. Cancer Res., 63, 8062-8068 (2003).
30. Shimada, T., Yamazaki, H., Foroozesh, M., Hopkins, N. E., Alworth, W. L., and Guengerich, F. P., Selectivity of polycyclic inhibitors for human cytochrome P450s 1A1, 1A2, and 1B1. Chem. Res. Toxicol., 11, 1048-1056 (1998).
31. Shin, N. H., Ryu, S. Y., Choi, E. J., Kang, S. H., Chang, I. M., Min, K. R., and Kim, Y., Oxyresveratrol as the potent inhibitor on dopa oxidase activity of mushroom tyrosinase. Biochem. Biophys. Res. Commun., 243, 801-803 (1998a).
32. Shin, N. H., Ryu, S. Y., Lee, H., Min, K. R., and Kim, Y., Inhibitory effects of hydroxystilbenes on cyclooxygenase from sheep seminal vesicles. Planta Med., 64, 283-284 (1998b).
33. Zhai, S., Dai, R., Friedman, F. K., and Vestal, R. E., Comparative inhibition of human cytochromes P450 1A1 and 1A2 by flavonoids. Drug Metab. Dispos., 26, 989-992 (1998).